Offer - Urjas Oil for just ₹ 1 X
Nebicard 10 Tablet is a prescription drug, available for use as Tablet. It is typically used for the treatment of High BP.
Medical history of the patient along with age and gender determines the dosage of Nebicard 10 Tablet. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
Besides the aforementioned side effects, there are other adverse effects of Nebicard 10 Tablet as well, which are listed below. Such side effects of Nebicard 10 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
Nebicard 10 Tablet's effect during pregnancy is Severe and Severe while nursing. It is important to know if Nebicard 10 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Nebicard 10 Tablet related warnings section.
Nebicard 10 Tablet is contraindicated in people with pre-existing medical conditions like Diabetes, Asthma, COPD (Chronic Obstructive Pulmonary Disease) as it can result in adverse effects. Other conditions have been mentioned below in the Nebicard 10 Tablet contraindications section.
Additionally, Nebicard 10 Tablet may also adversely react with other medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Nebicard 10 Tablet is considered not safe while driving, and is not addictive.
Nebicard 10 Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Nebicard 10 Tablet safe for pregnant women?
Nebicard shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Nebicard 10 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Nebicard. It should only be taken after medical advice.
What is the effect of Nebicard 10 Tablet on the Kidneys?
Nebicard has very mild side effects on the kidneys.
What is the effect of Nebicard 10 Tablet on the Liver?
Nebicard may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Nebicard 10 Tablet on the Heart?
Side effects of Nebicard rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Nebicard 10 Tablet unless your doctor advises you to do so -
Is this Nebicard 10 Tablet habit forming or addictive?
Nebicard 10 Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Nebicard 10 Tablet can make you feel drowsy.
Is it safe?
Yes, Nebicard 10 Tablet is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Nebicard 10 Tablet is unable to treat or cure mental disorders.
Interaction between Food and Nebicard 10 Tablet
Eating certain foods may increase the time it takes Nebicard 10 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Nebicard 10 Tablet
Consumption of alcohol and Nebicard 10 Tablet together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bystolic® (nebivolol)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 149-151
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 896-897